← Back
C2N
product
A commercial blood-based biomarker test for Alzheimer's disease detection and monitoring.
Also mentioned
(1)
Casual references without a clear endorsement
Peter Attia
mentioned
"We could look at C2N, we could look at PAL, we could look at any of the other brain metabolomics,..."
▶ 1:44:50